• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于特发性心肌病患者而言,若被认为身体状况过于良好而不适合进行移植,则其生存率较低。

Poor survival of patients with idiopathic cardiomyopathy considered too well for transplantation.

作者信息

Stevenson L W, Fowler M B, Schroeder J S, Stevenson W G, Dracup K A, Fond V

机构信息

Department of Medicine, UCLA Medical Center 90024-1679.

出版信息

Am J Med. 1987 Nov;83(5):871-6. doi: 10.1016/0002-9343(87)90644-9.

DOI:10.1016/0002-9343(87)90644-9
PMID:3314498
Abstract

Although the success of cardiac transplantation has encouraged earlier referral of potential candidates, those with mild symptoms of heart failure are frequently considered "too well" for transplantation. Outcome was investigated for 28 patients with non-ischemic dilated cardiomyopathy and ejection fraction of 25 percent or less who were denied transplantation due to lack of severe symptoms. One-year survival without transplantation was 46 percent. Low stroke volume and history of ventricular arrhythmias were independent predictors of early mortality. High risk, defined as either stroke volume of 40 ml or less or history of ventricular arrhythmia, identified 13 of 14 patients who did not survive one year and only one of 12 one-year survivors (p less than 0.001). Low stroke volume predicted hemodynamic failure (p less than 0.05) whereas arrhythmic history predicted sudden death (p less than 0.001). Clinical status improved in only six patients, all of whom had symptom duration of seven or less months at initial evaluation (p less than 0.001). Thus, patients referred to transplantation for dilated cardiomyopathy with an ejection fraction of 25 percent or less have a poor prognosis even if symptoms are mild. Patients with high hemodynamic risk may require early transplantation, whereas those with high arrhythmia risk may require other aggressive therapy in order to avoid transplantation until symptoms become severe.

摘要

尽管心脏移植的成功促使潜在候选者更早前来咨询,但那些有轻度心力衰竭症状的患者常常被认为“情况太好”而不适合进行移植。对28例非缺血性扩张型心肌病且射血分数在25%或更低、因缺乏严重症状而被拒绝移植的患者的预后进行了调查。未经移植的1年生存率为46%。低心排血量和室性心律失常病史是早期死亡的独立预测因素。高危定义为心排血量40ml或更低或有室性心律失常病史,在14例未存活1年的患者中识别出13例,而在12例1年存活者中仅识别出1例(p<0.001)。低心排血量预测血流动力学衰竭(p<0.05),而心律失常病史预测猝死(p<0.001)。仅6例患者的临床状况有所改善,所有这些患者在初始评估时症状持续时间均为7个月或更短(p<0.001)。因此,因扩张型心肌病前来咨询移植、射血分数在25%或更低的患者,即使症状轻微,预后也较差。血流动力学风险高的患者可能需要早期移植,而心律失常风险高的患者可能需要其他积极治疗,以便在症状变得严重之前避免移植。

相似文献

1
Poor survival of patients with idiopathic cardiomyopathy considered too well for transplantation.对于特发性心肌病患者而言,若被认为身体状况过于良好而不适合进行移植,则其生存率较低。
Am J Med. 1987 Nov;83(5):871-6. doi: 10.1016/0002-9343(87)90644-9.
2
Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation.心脏移植转诊后近期发生的心肌病改善情况的预测
J Am Coll Cardiol. 1994 Mar 1;23(3):553-9. doi: 10.1016/0735-1097(94)90735-8.
3
Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy.血流动力学对治疗的反应在预测继发于缺血性或非缺血性扩张型心肌病且射血分数小于或等于20%患者的生存中的重要性。
Am J Cardiol. 1990 Dec 1;66(19):1348-54. doi: 10.1016/0002-9149(90)91166-4.
4
Timing of cardiac transplantation in idiopathic dilated cardiomyopathy.特发性扩张型心肌病心脏移植的时机
Am J Cardiol. 1988 Feb 15;61(6):418-22. doi: 10.1016/0002-9149(88)90297-4.
5
Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy.特发性扩张型心肌病中左、右心室射血分数对长期生存的额外预测价值。
Eur Heart J. 1997 Feb;18(2):276-80. doi: 10.1093/oxfordjournals.eurheartj.a015231.
6
Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.过去 30 多年来,托斯卡纳地区特发性扩张型心肌病患者生存率的提高:基于证据的管理的影响。
Circ Heart Fail. 2013 Sep 1;6(5):913-21. doi: 10.1161/CIRCHEARTFAILURE.112.000120. Epub 2013 Jul 25.
7
Histomorphometric features predict 1-year outcome of patients with idiopathic dilated cardiomyopathy considered to be at low priority for cardiac transplantation.组织形态计量学特征可预测被认为心脏移植优先级较低的特发性扩张型心肌病患者的1年预后。
Am Heart J. 1994 Aug;128(2):316-25. doi: 10.1016/0002-8703(94)90485-5.
8
Mildly dilated congestive cardiomyopathy. Use of prospective diagnostic criteria and description of the clinical course without heart transplantation.轻度扩张型充血性心肌病。前瞻性诊断标准的应用及无心脏移植情况下临床病程的描述。
Circulation. 1990 Feb;81(2):506-17. doi: 10.1161/01.cir.81.2.506.
9
Outcomes of children following a first hospitalization for dilated cardiomyopathy.首次因扩张型心肌病住院患儿的结局。
Circ Heart Fail. 2012 Jul 1;5(4):437-43. doi: 10.1161/CIRCHEARTFAILURE.111.964510. Epub 2012 May 8.
10
Natural history of dilated cardiomyopathy in children.儿童扩张型心肌病的自然病史。
Am Heart J. 1991 May;121(5):1502-6. doi: 10.1016/0002-8703(91)90158-e.

引用本文的文献

1
Surgical treatment of functional mitral regurgitation in dilated cardiomyopathy.扩张型心肌病功能性二尖瓣反流的外科治疗
J Saudi Heart Assoc. 2011 Jul;23(3):125-34. doi: 10.1016/j.jsha.2011.04.001. Epub 2011 Apr 16.
2
Prevalence and incidence of arrhythmias and sudden death in heart failure.心力衰竭中心律失常和猝死的患病率与发病率
Heart Fail Rev. 2002 Jul;7(3):229-42. doi: 10.1023/a:1020024122726.
3
Mitral valve reconstruction in the patient with heart failure.
Heart Fail Rev. 2001 Sep;6(3):177-85. doi: 10.1023/a:1011421014480.
4
Surgical alternatives to transplantation and assist devices in the treatment of heart failure.治疗心力衰竭时移植和辅助装置的手术替代方案。
Curr Cardiol Rep. 2000 Nov;2(6):564-71. doi: 10.1007/s11886-000-0043-0.
5
Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing.血管紧张素转换酶(ACE)抑制剂与心力衰竭。处方不足的后果。
Pharmacoeconomics. 1999 Jun;15(6):535-50. doi: 10.2165/00019053-199915060-00002.
6
Implications for present and future applications of the implantable cardioverter-defibrillator resulting from the use of a simple model of cost efficacy.使用简单成本效益模型对植入式心脏复律除颤器当前及未来应用的启示。
Br Heart J. 1993 Jan;69(1):83-92. doi: 10.1136/hrt.69.1.83.
7
Cardiac transplantation. Selection, immunosuppression, and survival.心脏移植。选择、免疫抑制与存活情况。
West J Med. 1988 Nov;149(5):572-82.
8
Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy.对于慢性缺血性心肌病,应选择冠状动脉血运重建而非心脏移植。
Ann Surg. 1989 Sep;210(3):348-52; discussion 352-4. doi: 10.1097/00000658-198909000-00011.
9
Effectiveness of long-term beta-blocker therapy for dilated cardiomyopathy--echocardiographical follow-up.
Cardiovasc Drugs Ther. 1991 Apr;5(2):463-9. doi: 10.1007/BF03029771.